GlassScriptPhysician profile
James A Sylora
NPI 1245296912
$55,116.84
in general payments reported to CMS, 2019-2025
59 companies · $8,277 in 2025
The $8,277 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,149 · 2021: $1,324 · 2022: $16K · 2023: $13K · 2024: $838 · 2025: $8,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,035 · Travel and Lodging: $6,573 · Food and Beverage: $5,034 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,035.06 |
| Travel and Lodging | $6,572.75 |
| Food and Beverage | $5,033.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $31,884.66 | 2019-2025 | Da Vinci Surgical System |
| Histosonics, INC. | $3,803.55 | 2025 | |
| Integra Gpo, LLC | $3,649.74 | 2019 | |
| Angiodynamics, INC. | $3,024.31 | 2021-2022 | |
| Clovis Oncology, INC. | $2,555.64 | 2019 | |
| Avyxa Pharma, LLC | $2,511.87 | 2025 | |
| Olympus America INC. | $695.46 | 2022-2025 | Itind System |
| Boston Scientific Corporation | $602.81 | 2019-2025 | Ams 700 |
| Teleflex LLC | $518.00 | 2021-2025 | Barrigel, Urolift |
| Astellas Pharma US INC | $507.06 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $432.98 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $380.33 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $350.37 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $286.08 | 2019-2023 | Provenge |
| Blue Earth Diagnostics | $256.79 | 2021-2025 | Posluma |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $254.68 | 2021 | |
| Axonics, INC. | $234.81 | 2021-2022 | |
| Myovant Sciences INC. | $209.78 | 2021-2022 | |
| Antares Pharma, INC. | $204.77 | 2019-2025 | Xyosted |
| Abbvie INC. | $191.44 | 2019-2025 | Lupron Depot |
| Medtronic, INC. | $174.34 | 2022 | |
| Coloplast Corp | $165.70 | 2019-2025 | Porges Coloplast |
| Myriad Genetic Laboratories, INC. | $155.03 | 2021-2025 | Prolaris, Myrisk |
| Agiliti Surgical, INC. | $148.59 | 2025 | Siemens Healthineers Varian Cryocare, Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Progenics Pharmaceuticals, INC. | $146.93 | 2021-2025 | |
| Neotract INC. | $144.72 | 2019 | |
| Pfizer INC. | $144.29 | 2019-2020 | |
| Convatec INC. | $143.72 | 2021-2022 | |
| Procept Biorobotics Corporation | $139.32 | 2019-2025 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $113.90 | 2019-2025 | |
| Comsort, INC | $100.00 | 2019 | |
| Urogen Pharma, INC. | $96.78 | 2023-2025 | Jelmyto |
| Varian Medical Systems, INC. | $94.86 | 2019 | |
| Tolmar, INC. | $86.28 | 2023-2025 | Eligard, Jatenzo |
| Tolmar Pharmaceuticals, INC. | $81.64 | 2019-2022 | |
| Calyxo, INC. | $80.61 | 2023-2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $78.35 | 2022-2025 | Keytruda, Keytruda Qlex |
| Endo Pharmaceuticals INC. | $50.97 | 2019-2021 | |
| Allergan, INC. | $45.14 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Clarus Therapeutics INC. | $32.08 | 2021 | |
| Amgen INC. | $27.09 | 2019 | |
| Cardinal Health 414 LLC | $24.74 | 2023 | |
| Genzyme Corporation | $23.08 | 2022 | |
| Janssen Scientific Affairs, LLC | $22.76 | 2019 | |
| Hollister Incorporated | $21.91 | 2023 | Onli, Infyna Chic, Vapro Plus Pocket |
| Sun Pharmaceutical Industries INC. | $19.26 | 2019 | |
| Civco Medical Instruments | $19.12 | 2025 | |
| Axogen | $17.64 | 2025 | |
| Tempus Ai, INC | $17.28 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.15 | 2025 | |
| Edap Technomed INC | $16.37 | 2023 | |
| Abc Home Medical Supply, INC. | $16.17 | 2024 | |
| Alnylam Pharmaceuticals INC. | $15.72 | 2021 | |
| Halozyme INC | $15.04 | 2023 | |
| Ambu INC. | $14.92 | 2023 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 | |
| Travere Therapeutics, INC. | $6.61 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sylora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.